Neurogen Brain And Spine Institute Profile
Key Indicators
- Authorised Capital ₹ 18.00 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -100.00%
- Profit Growth -2630.61%
- Ebitda -385.31%
- Net Worth -6.54%
- Total Assets 6.28%
About Neurogen Brain And Spine Institute
Neurogen Brain And Spine Institute Private Limited (NBASIPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 October 2010 and has a history of 14 years and four months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 18.00 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Alok Kundanlal and Alisha Sharma serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85110MH2010PTC208641
- Company No.
208641
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Oct 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Neurogen Brain And Spine Institute?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Kundanlal  | Director | 05-Oct-2010 | Current |
| Alisha Sharma | Director | 24-Apr-2019 | Current |
Financial Performance of Neurogen Brain And Spine Institute.
Neurogen Brain And Spine Institute Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 2630.61% decrease in profit. The company's net worth dipped by a decrease of 6.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neurogen Brain And Spine Institute?
Unlock access to Neurogen Brain And Spine Institute's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kls Welness Institute LlpAlok Kundanlal and Alisha Sharma are mutual person
- Autism Connect Llp
Alok Kundanlal and Alisha Sharma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neurogen Brain And Spine Institute?
Unlock and access historical data on people associated with Neurogen Brain And Spine Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neurogen Brain And Spine Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neurogen Brain And Spine Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
